Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thyroid dysfunction associated with immunotherapy for patients with cancer.

D J Schwartzentruber1, D E White, M H Zweig

  • 1Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

Cancer
|December 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Visualization of periurethral structures by 3D endovaginal ultrasonography in midsagittal plane is not associated with stress urinary incontinence status.

International urogynecology journal·2012
Same author

Fenretinide-dependent upregulation of death receptors through ASK1 and p38α enhances death receptor ligand-induced cell death in Ewing's sarcoma family of tumours.

British journal of cancer·2010
Same author

Integrin-linked kinase has a critical role in ErbB2 mammary tumor progression: implications for human breast cancer.

Oncogene·2010
Same author

The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer.

Oncogene·2007
Same author

Clinical pathways for managing patients receiving interleukin 2.

Clinical journal of oncology nursing·2002
Same author

Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV.

The Journal of experimental medicine·2001
Same journal

Real-world effectiveness of chemotherapy regimens after immunotherapy in patients with advanced melanoma in Spain: Results from the GEM1801 study.

Cancer·2026
Same journal

Bendamustine in indolent lymphoma: Letting the dust settle down.

Cancer·2026
Same journal

Top advances of the year: Bispecific antibodies in early lines of therapy in multiple myeloma.

Cancer·2026
Same journal

Direct oral anticoagulants and warfarin in atrial fibrillation patients with cancer by anticoagulation quality.

Cancer·2026
Same journal

Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.

Cancer·2026
Same journal

Toward exercise as standard care for older cancer survivors.

Cancer·2026
See all related articles

Interleukin-2 (IL-2) immunotherapy frequently causes thyroid dysfunction in cancer patients. Monitoring thyroid function is crucial due to high rates of hypothyroidism and hyperthyroidism during and after treatment.

Area of Science:

  • Endocrinology
  • Oncology
  • Immunotherapy

Background:

  • Interleukin-2 (IL-2)-based immunotherapy is used for cancer treatment.
  • The impact of IL-2 on thyroid function is not fully understood.

Purpose of the Study:

  • To prospectively evaluate the incidence and characteristics of thyroid dysfunction in cancer patients undergoing IL-2 immunotherapy.

Main Methods:

  • Prospective study of 130 cancer patients receiving IL-2 immunotherapy.
  • Thyroid function tests and antibody levels were assessed before, during, and after treatment.

Main Results:

  • Primary hypothyroidism was common, rising from 12% before to 38% during therapy.
  • Hyperthyroidism occurred in up to 7% of patients post-therapy.

Related Experiment Videos

  • Thyroid dysfunction was independent of patient demographics, cancer type, or treatment response.

    • Conclusions:

    • IL-2 immunotherapy is associated with a high incidence of thyroid dysfunction.
    • Routine monitoring of thyroid function is recommended for patients receiving IL-2 therapy.